Veranova, L.P.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2003 Nolte Drive, West Deptford, New Jersey (NJ) 08066, United States (USA)
- Operations here
- api manufacture
- FDA identifiers
- FEI 2245277 · DUNS 808176705
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-01-23
- VAIDrug Quality Assurance2023-02-15
- VAIDrug Quality Assurance2019-03-08
- VAIDrug Quality Assurance2018-01-31
- NAIDrug Quality Assurance2016-05-05
- NAIDrug Quality Assurance2013-10-31
- NAIDrug Quality Assurance2012-06-21
- NAIDrug Quality Assurance2010-06-11
Drugs this plant is listed as making
4 distinct drugs across 12 products name this site in their FDA label.
- Benzhydrocodone and AcetaminophenZevra Therapeutics, Inc.
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
- Methylphenidate Hydrochloridein shortageAmneal Pharmaceuticals of New York LLC
- oxaliplatinWinthrop U.S, a business of sanofi-aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.